Acute respiratory distress syndrome (ARDS) is characterized by refractory hypoxemia caused by accumulation of pulmonary fluid with a high mortality rate, but the underlying mechanism is not yet fully understood, causing absent specific therapeutic drugs to treat with ARDS. In recent years, more and more studies have applied proteomics to ARDS. Non-targeted studies of proteomics in ARDS are just beginning and have the potential to identify novel drug targets and key pathways in this disease. This paper will provide a brief review of the recent advances in the application of non-targeted proteomics to ARDS.
All Keywords
【저자키워드】 ARDS, Clinical applications, Study designs, Non-targeted proteomics, 【초록키워드】 proteomics, Hypoxemia, pathway, drug target, disease, mechanism, distress, syndrome, treat, high mortality rate, identify, caused, applied, characterized, therapeutic drug, 【제목키워드】 proteomics, Research, acute respiratory distress,
【저자키워드】 ARDS, Clinical applications, Study designs, Non-targeted proteomics, 【초록키워드】 proteomics, Hypoxemia, pathway, drug target, disease, mechanism, distress, syndrome, treat, high mortality rate, identify, caused, applied, characterized, therapeutic drug, 【제목키워드】 proteomics, Research, acute respiratory distress,